QuintilesIMS to Host Financial Analyst and Investor Conference on November 8, 2017
October 04 2017 - 4:15PM
Business Wire
Quintiles IMS Holdings, Inc. (“QuintilesIMS”) (NYSE:Q) will host
an Analyst and Investor Conference in New York City on Wednesday,
November 8, 2017. Management will provide an update on the business
and progress since the merger. The presentations will begin at 9:00
a.m. ET and will conclude at approximately 1:00 p.m. Registration
is required to attend the event.
All are invited to listen to the live event and view the
presentation slides via webcast on the QuintilesIMS Investor
Relations website at http://ir.quintilesims.com. The discussion
will also be available by dialing +1-800-672-6112 in the U.S. and
Canada, or +1-303-223-4370 for international callers.
A replay of the webcast will be available later that day,
following the conclusion of the live event. To access the webcast
recording, visit http://ir.quintilesims.com.
About QuintilesIMS
QuintilesIMS (NYSE:Q) is a leading integrated information and
technology-enabled healthcare service provider worldwide, dedicated
to helping its clients improve their clinical, scientific and
commercial results. Formed through the merger of Quintiles
Transnational and IMS Health, QuintilesIMS’s approximately 50,000
employees conduct operations in more than 100 countries. Companies
seeking to improve real-world patient outcomes through treatment
innovations, care provision and access can leverage QuintilesIMS’s
broad range of healthcare information, technology and service
solutions to drive new insights and approaches. QuintilesIMS
provides solutions that span clinical to commercial, bringing
customers a unique opportunity to realize the full potential of
innovations and advanced healthcare outcomes.
As a global leader in protecting individual patient privacy,
QuintilesIMS uses healthcare data to deliver critical, real-world
disease and treatment insights. Through a wide variety of
privacy-enhancing technologies and safeguards, QuintilesIMS
protects individual privacy while managing information to drive
healthcare forward. These insights and execution capabilities help
biotech, medical device and pharmaceutical companies, medical
researchers, government agencies, payers and other healthcare
stakeholders in the development and approval of new therapies, and
to identify unmet treatment needs and understand the safety,
effectiveness and value of pharmaceutical products in improving
overall health outcomes. To learn more, visit
www.QuintilesIMS.com.
QUINTILESIMSFIN
Click here to subscribe to Mobile Alerts for QuintilesIMS.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171004006096/en/
Quintiles IMS Holdings, Inc.Investor Relations:Andrew Markwick,
+1-973-257-7144andrew.markwick@quintilesims.comorMedia
Relations:Tor Constantino,
+1-484-567-6732tor.constantino@quintilesims.com
IQVIA (NYSE:IQV)
Historical Stock Chart
From Aug 2024 to Sep 2024
IQVIA (NYSE:IQV)
Historical Stock Chart
From Sep 2023 to Sep 2024